ADVERTISEMENT

Buy, Sell Or Hold: MCX, ABB, Wockhardt, Zydus Life, Shilpa Medicare — Ask Profit

Analysts also offered insights on the share price of PNB Housing Finance.

<div class="paragraphs"><p>Buy, Sell Or Hold: MCX, ABB, Wockhardt, Zydus Life, Shilpa Medicare, PNB Housing — Ask Profit (Photo: Gemini)</p></div>
Buy, Sell Or Hold: MCX, ABB, Wockhardt, Zydus Life, Shilpa Medicare, PNB Housing — Ask Profit (Photo: Gemini)
Show Quick Read
Summary is AI Generated. Newsroom Reviewed

Should you hold shares of Shilpa Medicare Ltd? Should you add shares of Zydus Lifesciences Ltd at the current market price? Have you lost the chance to buy shares of Wockhardt Ltd at an attractive price? Is it the right time to exit PNB Housing Finance Ltd?

Avinash Gorakshakar, director of research at Profitmart Securities, and Sarvendra Srivastava of @5WavesOfficial provided insights on these investor queries and more on NDTV Profit's Ask Profit show.

Multi Commodity Exchange of India (CMP: Rs 8,339)

Gorakshakar: Avoid

  • Valuations are not cheap.

  • Paying a premium to buy this.

  • Many other market intermediaries like NSDL.

  • Invest in those capital market intermediaries, which are slightly not overbought by the institutions.

  • Computer Age Management Services is also a good idea.

  • These can be bought on every dip on SIP basis.

Opinion
MCX Q1 Results: Profit Up 50%

ABB India (CMP: Rs 5,087)

Srivastava: Hold

  • Give it some time.

  • Stock is in downtrend.

  • Will take some time to repair the damage that will be done.

  • May take six months, will keep giving bounces.

  • Give it 9-12 months to see Rs 5,900 levels.

Opinion
ABB India Q2 Results: Profit Down 21%, Misses Estimates

Wockhardt (CMP: Rs 1,501.6)

Gorakshakar: Hold

  • Hold 75% of the shares.

  • Coming three months will be challenging for Pharma due to Trump tariffs.

  • There will be good risk-reward opportunities with regards to the products they will be releasing in the coming years.

Opinion
Wockhardt Eyes ‘Healthy Bottom Line’ In Coming Quarters Amid US Tariff Concerns

Zydus Lifesciences (CMP: Rs 988.6)

Srivastava: Avoid

  • Underperformed over the last couple of months.

  • It's US-centric.

  • Nothing has been there on the plate yet.

  • Deadlines are closing in, let's see what the Trump administration will say.

  • Avoid for the time being.

  • Wait out this space for the next 15 days.

Shilpa Medicare (CMP: Rs 906.2)

Srivastava: Hold

  • Risk-rewards not favouring a short term trade.

  • Wait out the next 15-20 days before considering investment.

  • Levels to accumulate are Rs 800.

Opinion
Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples — Check Record Date

PNB Housing Finance (CMP: Rs 772.95)

Srivastava: Hold

  • The stock has gap-down after that news.

  • Once you have such corporate developments going around, the stock loses flavour for some time.

  • Good pedigree but good stock, bad timing.

  • Repair process will take time, wait it out.

  • Very difficult to say to book losses.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.

Opinion
PNB Housing Finance: CEO Resignation Abrupt, But Franchise Fundamentals Intact— Motilal Oswal Maintains 'Buy'
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit